Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex

Journal of Biological Chemistry

Volumn 287, Issue 16, 2012, Pages 13216-13227

  Joe, Myung Kuk ^a   Kee, Changwon ^b   Tomarev, Stanislav I ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AVERAGE SIZE; GENETIC STUDIES; KEY REGULATORS; LAMININ; MUSCLE ATROPHY; MUSCLE FIBER; MUSCLE SIZE; MYOCILIN; MYOTUBES; N-TERMINAL DOMAINS; NITRIC-OXIDE SYNTHASE; OPEN-ANGLE GLAUCOMA; PROTEIN COMPLEXES; RING FINGER; SKELETAL MUSCLE; SYNTROPHINS; TRANSGENIC MICE;

MAMMALS; PHOSPHORYLATION; PROTEINS;

MUSCLE;

ALPHA DYSTROGLYCAN; ALPHA1 SYNTROPHIN; ATROGIN 1; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; FORKHEAD TRANSCRIPTION FACTOR; LAMININ; MUSCLE RING FINGER 1 PROTEIN; MYOCILIN; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; SYNTROPHIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; MOUSE; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; MUSCLE MASS; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; UPREGULATION;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CYTOPLASM; CYTOSKELETAL PROTEINS; DYSTROPHIN; EYE PROTEINS; GENE EXPRESSION; GLYCOPROTEINS; HYPERTROPHY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOBLASTS; SIGNAL TRANSDUCTION; UP-REGULATION;

MUS MUSCULUS;

EID: 84859742692     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.224063     Document Type: Article

References (66)

1. Polansky, J. R., Fauss, D. J., Chen, P., Chen, H., Lütjen-Drecoll, E., Johnson, D., Kurtz, R. M., Ma, Z. D., Bloom, E., and Nguyen, T. D. (1997) Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 211, 126-139 (Pubitemid 27223561)
2. Tomarev, S. I., and Nakaya, N. (2009) Olfactomedin domain-containing proteins. Possible mechanisms of action and functions in normal development and pathology. Mol. Neurobiol. 40, 122-138
3. Nguyen, T. D., Chen, P., Huang, W. D., Chen, H., Johnson, D., and Polansky, J. R. (1998) Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J. Biol. Chem. 273, 6341-6350 (Pubitemid 28144725)
4. Fautsch, M. P., and Johnson, D. H. (2001) Characterization of myocilinmyocilin interactions. Invest. Ophthalmol. Vis. Sci. 42, 2324-2331
5. Torrado, M., Trivedi, R., Zinovieva, R., Karavanova, I., and Tomarev, S. I. (2002) Optimedin. A novel olfactomedin-related protein that interacts with myocilin. Hum. Mol. Genet. 11, 1291-1301 (Pubitemid 34555526)
6. Wentz-Hunter, K., Ueda, J., and Yue, B. Y. (2002) Protein interactions with myocilin. Invest. Ophthalmol. Vis. Sci. 43, 176-182 (Pubitemid 34032457)
7. Fingert, J. H., Ying, L., Swiderski, R. E., Nystuen, A. M., Arbour, N. C., Alward, W. L., Sheffield, V. C., and Stone, E. M. (1998) Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 8, 377-384 (Pubitemid 28209976)
8. Stone, E. M., Fingert, J. H., Alward, W. L., Nguyen, T. D., Polansky, J. R., Sunden, S. L., Nishimura, D., Clark, A. F., Nystuen, A., Nichols, B. E., Mackey, D. A., Ritch, R., Kalenak, J. W., Craven, E. R., and Sheffield, V. C. (1997) Identification of a gene that causes primary open angle glaucoma. Science 275, 668-670 (Pubitemid 27061334)
9. Kwon, Y. H., Fingert, J. H., Kuehn, M. H., and Alward, W. L. (2009) Primary open-angle glaucoma. N. Engl. J. Med. 360, 1113-1124
10. Adam, M. F., Belmouden, A., Binisti, P., Brézin, A. P., Valtot, F., Béchetoille, A., Dascotte, J. C., Copin, B., Gomez, L., Chaventré, A., Bach, J. F., and Garchon, H. J. (1997) Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin homology domain of TIGR in familial open-angle glaucoma. Hum. Mol. Genet. 6, 2091-2097 (Pubitemid 27477951)
11. Quigley, H. A., and Broman, A. T. (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90, 262-267
12. Jacobson, N., Andrews, M., Shepard, A. R., Nishimura, D., Searby, C., Fingert, J. H., Hageman, G., Mullins, R., Davidson, B. L., Kwon, Y. H., Alward, W. L., Stone, E. M., Clark, A. F., and Sheffield, V. C. (2001) Nonsecretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum. Mol. Genet. 10, 117-125 (Pubitemid 32098121)
13. Gobeil, S., Rodrigue, M. A., Moisan, S., Nguyen, T. D., Polansky, J. R., Morissette, J., and Raymond, V. (2004) Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest. Ophthalmol. Vis. Sci. 45, 3560-3567 (Pubitemid 39298574)
14. Malyukova, I., Lee, H. S., Fariss, R. N., and Tomarev, S. I. (2006) Mutated mouse and human myocilins have similar properties and do not block general secretory pathway. Invest. Ophthalmol. Vis. Sci. 47, 206-212 (Pubitemid 46780815)
15. Sohn, S., Hur, W., Joe, M. K., Kim, J. H., Lee, Z. W., Ha, K. S., and Kee, C. (2002) Expression of wild-type and truncated myocilins in trabecular meshwork cells. Their subcellular localizations and cytotoxicities. Invest. Ophthalmol. Vis. Sci. 43, 3680-3685 (Pubitemid 35470604)
16. Joe, M. K., Sohn, S., Hur, W., Moon, Y., Choi, Y. R., and Kee, C. (2003) Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem. Biophys. Res. Commun. 312, 592-600 (Pubitemid 37468212)
17. Liu, Y., and Vollrath, D. (2004) Reversal of mutant myocilin non-secretion and cell killing. Implications for glaucoma. Hum. Mol. Genet. 13, 1193-1204 (Pubitemid 38787001)
18. Joe, M. K., and Tomarev, S. I. (2010) Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis. Implication for glaucoma pathogenesis. Am. J. Pathol. 176, 2880-2890
19. Tomarev, S. I., Tamm, E. R., and Chang, B. (1998) Characterization of the mouse Myoc/Tigr gene. Biochem. Biophys. Res. Commun. 245, 887-893 (Pubitemid 28414013)
20. Kim, B. S., Savinova, O. V., Reedy, M. V., Martin, J., Lun, Y., Gan, L., Smith, R. S., Tomarev, S. I., John, S. W., and Johnson, R. L. (2001) Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol. Cell. Biol. 21, 7707-7713 (Pubitemid 32988780)
21. Lam, D. S., Leung, Y. F., Chua, J. K., Baum, L., Fan, D. S., Choy, K. W., and Pang, C. P. (2000) Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 41, 1386-1391 (Pubitemid 30261861)
22. Kwon, H. S., Lee, H. S., Ji, Y., Rubin, J. S., and Tomarev, S. I. (2009) Myocilin is a modulator of Wnt signaling. Mol. Cell. Biol. 29, 2139-2154
23. Joe, M. K., Sohn, S., Choi, Y. R., Park, H., and Kee, C. (2005) Identification of flotillin-1 as a protein interacting with myocilin. Implications for the pathogenesis of primary open-angle glaucoma. Biochem. Biophys. Res. Commun. 336, 1201-1206 (Pubitemid 41383449)
24. Veroni, C., Grasso, M., Macchia, G., Ramoni, C., Ceccarini, M., Petrucci, T. C., and Macioce, P. (2007) --Dystrobrevin, a kinesin-binding receptor, interacts with the extracellular matrix components pancortins. J. Neurosci. Res. 85, 2631-2639 (Pubitemid 47344565)
25. Waite, A., Tinsley, C. L., Locke, M., and Blake, D. J. (2009) The neurobiology of the dystrophin-associated glycoprotein complex. Ann. Med. 41, 344-359
26. Ehmsen, J., Poon, E., and Davies, K. (2002) The dystrophin-associated protein complex. J. Cell Sci. 115, 2801-2803
27. Hynes, R. O., and Zhao, Q. (2000) The evolution of cell adhesion. J. Cell Biol. 150, F89-F96
28. Piluso, G., Mirabella, M., Ricci, E., Belsito, A., Abbondanza, C., Servidei, S., Puca, A. A., Tonali, P., Puca, G. A., and Nigro, V. (2000) γ1- and γ2- syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J. Biol. Chem. 275, 15851-15860 (Pubitemid 30366886)
29. Peters, M. F., Adams, M. E., and Froehner, S. C. (1997) Differential association of syntrophin pairs with the dystrophin complex. J. Cell Biol. 138, 81-93 (Pubitemid 27337454)
30. Ahn, A. H., Freener, C. A., Gussoni, E., Yoshida, M., Ozawa, E., and Kunkel, L. M. (1996) The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J. Biol. Chem. 271, 2724-2730 (Pubitemid 26047889)
31. Kim, M. J., Hwang, S. H., Lim, J. A., Froehner, S. C., Adams, M. E., and Kim, H. S. (2010) A-syntrophin modulates myogenin expression in differentiating myoblasts. PLoS ONE 5, e15355
32. Ervasti, J. M., and Sonnemann, K. J. (2008) Biology of the striated muscle dystrophin-glycoprotein complex. Int. Rev. Cytol. 265, 191-225 (Pubitemid 351215989)
33. Gould, D. B., Miceli-Libby, L., Savinova, O. V., Torrado, M., Tomarev, S. I., Smith, R. S., and John, S. W. (2004) Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol. Cell. Biol. 24, 9019-9025 (Pubitemid 39313906)
34. Yoshida, M., Hama, H., Ishikawa-Sakurai, M., Imamura, M., Mizuno, Y., Araishi, K., Wakabayashi-Takai, E., Noguchi, S., Sasaoka, T., and Ozawa, E. (2000) Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum. Mol. Genet. 9, 1033-1040 (Pubitemid 30216008)
35. Bunnell, T. M., Jaeger, M. A., Fitzsimons, D. P., Prins, K. W., and Ervasti, J. M. (2008) Destabilization of the dystrophin-glycoprotein complex without functional deficits in α-dystrobrevin null muscle. PLoS ONE 3, e2604
36. Xiong, Y., Zhou, Y., and Jarrett, H. W. (2009) Dystrophin glycoprotein complex-associated Gβγ subunits activate phosphatidylinositol 3-kinase/ Akt signaling in skeletal muscle in a laminin-dependent manner. J. Cell. Physiol. 219, 402-414
37. Langenbach, K. J., and Rando, T. A. (2002) Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 26, 644-653 (Pubitemid 35266088)
38. Sandri, M. (2008) Signaling in muscle atrophy and hypertrophy. Physiology 23, 160-170
39. Glass, D. J. (2005) A signaling role for dystrophin. Inhibiting skeletal muscle atrophy pathways. Cancer Cell 8, 351-352
40. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412 (Pubitemid 38534545)
41. Suzuki, N., Motohashi, N., Uezumi, A., Fukada, S., Yoshimura, T., Itoyama, Y., Aoki, M., Miyagoe-Suzuki, Y., and Takeda, S. (2007) NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J. Clin. Invest. 117, 2468-2476 (Pubitemid 47494348)
42. Senf, S. M., Dodd, S. L., McClung, J. M., and Judge, A. R. (2008) Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 22, 3836-3845
43. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., Pan, Z. Q., Valenzuela, D. M., DeChiara, T. M., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708 (Pubitemid 33104839)
44. Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., and Yancopoulos, G. D. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019 (Pubitemid 34428747)
45. Gullberg, D., Tiger, C. F., and Velling, T. (1999) Laminins during muscle development and in muscular dystrophies. Cell. Mol. Life Sci. 56, 442-460 (Pubitemid 29520834)
46. Oti, M., Snel, B., Huynen, M. A., and Brunner, H. G. (2006) Predicting disease genes using protein-protein interactions. J. Med. Genet. 43, 691-698 (Pubitemid 44214908)
47. Fautsch, M. P., Vrabel, A. M., and Johnson, D. H. (2006) The identification of myocilin-associated proteins in the human trabecular meshwork. Exp. Eye Res. 82, 1046-1052
48. Leung-Hagesteijn, C. Y., Milankov, K., Michalak, M., Wilkins, J., and Dedhar, S. (1994) Cell attachment to extracellular matrix substrates is inhibited upon down-regulation of expression of calreticulin, an intracellular integrin α-subunit-binding protein. J. Cell Sci. 107, 589-600 (Pubitemid 24091864)
49. Burns, K., Duggan, B., Atkinson, E. A., Famulski, K. S., Nemer, M., Bleackley, R. C., and Michalak, M. (1994) Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367, 476-480 (Pubitemid 24046052)
50. Iakova, P., Wang, G. L., Timchenko, L., Michalak, M., Pereira-Smith, O. M., Smith, J. R., and Timchenko, N. A. (2004) Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 23, 406-417 (Pubitemid 38294505)
51. Resch, Z. T., Hann, C. R., Cook, K. A., and Fautsch, M. P. (2010) Aqueous humor rapidly stimulates myocilin secretion from human trabecular meshwork cells. Exp. Eye Res. 91, 901-908
52. Hardy, K. M., Hoffman, E. A., Gonzalez, P., McKay, B. S., and Stamer, W. D. (2005) Extracellular trafficking of myocilin in human trabecular meshwork cells. J. Biol. Chem. 280, 28917-28926 (Pubitemid 41161337)
53. Zhou, Y., Grinchuk, O., and Tomarev, S. I. (2008) Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest. Ophthalmol. Vis. Sci. 49, 1932-1939
54. Wakayama, Y., Inoue, M., Kojima, H., Jimi, T., Yamashita, S., Kumagai, T., Shibuya, S., Hara, H., and Oniki, H. (2006) Altered α1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies. Histol. Histopathol. 21, 23-34 (Pubitemid 43033713)
55. Nakamori, M., Kimura, T., Kubota, T., Matsumura, T., Sumi, H., Fujimura, H., Takahashi, M. P., and Sakoda, S. (2008) Aberrantly spliced α-dystrobrevin alters α-syntrophin binding in myotonic dystrophy type 1. Neurology 70, 677-685
56. Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Mediation of IGF-1- induced skeletal myotube hypertrophy by PI3K/Akt/mTOR and PI3K/ Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013 (Pubitemid 34428746)
57. Raffaello, A., Milan, G., Masiero, E., Carnio, S., Lee, D., Lanfranchi, G., Goldberg, A. L., and Sandri, M. (2010) JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. J. Cell Biol. 191, 101-113
58. Kwon, H. S., and Tomarev, S. I. (2011) Myocilin, a glaucoma-associated protein, promotes cell migration through activation of integrin-focal adhesion kinase-serine/threonine kinase signaling pathway. J. Cell. Physiol. 226, 3392-3402
59. Wu, Y., Zhao, W., Zhao, J., Zhang, Y., Qin, W., Pan, J., Bauman, W. A., Blitzer, R. D., and Cardozo, C. (2010) REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 151, 1050-1059
60. Carraro, L., Ferraresso, S., Cardazzo, B., Romualdi, C., Montesissa, C., Gottardo, F., Patarnello, T., Castagnaro, M., and Bargelloni, L. (2009) Expression profiling of skeletal muscle in young bulls treated with steroidal growth promoters. Physiol. Genomics 38, 138-148
61. Komamura, K., Shirotani-Ikejima, H., Tatsumi, R., Tsujita-Kuroda, Y., Kitakaze, M., Miyatake, K., Sunagawa, K., and Miyata, T. (2003) Differential gene expression in the rat skeletal and heart muscle in glucocorticoidinduced myopathy. Analysis by microarray. Cardiovasc. Drugs Ther. 17, 303-310 (Pubitemid 37500181)
62. Schakman, O., Gilson, H., and Thissen, J. P. (2008) Mechanisms of glucocorticoid- induced myopathy. J. Endocrinol. 197, 1-10
63. Hasselgren, P. O., Alamdari, N., Aversa, Z., Gonnella, P., Smith, I. J., and Tizio, S. (2010) Corticosteroids and muscle wasting. Role of transcription factors, nuclear cofactors, and hyperacetylation. Curr. Opin. Clin. Nutr. Metab. Care 13, 423-428
64. Senatorov, V., Malyukova, I., Fariss, R., Wawrousek, E. F., Swaminathan, S., Sharan, S. K., and Tomarev, S. (2006) Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J. Neurosci. 26, 11903-11914 (Pubitemid 44772101)
65. Tamm, E. R. (2009) The trabecular meshwork outflow pathways. Structural and functional aspects. Exp. Eye Res. 88, 648-655
66. Alm, A., and Nilsson, S. F. (2009) Uveoscleral outflow. A review. Exp. Eye Res. 88, 760-768